New 3,4-bis(indol-1-yl)maleimides as protein kinase inhibitors
Article
First Online:
- 16 Downloads
Several previously unknown derivatives of 3,4-bis(indol-1-yl)maleimide, as well as 3-(2,3-dihydroindol-1-yl)-4-(indol-1-yl)maleimide were synthesized as potential analogs for a known series of protein kinase inhibitors BIS I, IV, IX containing the structural motif of 3,4-bis(indol-3-yl)maleimide. The activity of these synthesized compounds was characterized with regard to several human protein kinases and their cytotoxicity was determined.
Keywords
indole indolylmaleimides antitumor drugs protein kinases protein kinase inhibitorsReferences
- 1.Goekjian, P. G.; Jirousek, M. R. Expert Opin. Invest. Drugs 2001, 10, 2117.CrossRefGoogle Scholar
- 2.Fabbro, D.; Ruetz, S.; Buchdunger, E.; Cowan-Jacob, S. W.; Fendrich, G.; Liebetanz, J.; Mestan, J.; O'Reilly, T.; Traxler, P.; Chaudhuri, B.; Fretz, H.; Zimmermann, J.; Meyer, T.; Caravatti, G.; Furet, P.; Manley, P. W. Pharmacol. Ther. 2002, 93, 79.CrossRefGoogle Scholar
- 3.Davis, P. D.; Elliott, L. H.; Harris, W.; Hill, C. H.; Hurst, S. A.; Keech, E.; Kumar, M. K. H.; Lawton, G.; Nixon, J. S.; Wilkinson, S. E. J. Med. Chem. 1992, 35, 994.CrossRefGoogle Scholar
- 4.Davis, P. D.; Hill, C. H.; Lawton, G.; Nixon, J. S.; Wilkinson, S. E.; Hurst, S. A.; Keech, E.; Turner, S. E. J. Med. Chem. 1992, 35, 177.CrossRefGoogle Scholar
- 5.Jirousek, M. R.; Gillig, J. R.; Neel, D. A.; Rito, C. J.; O'bannon, D.; Heath, W. F.; McDonald III, J. H.; Faul, M. M.; Winneroski, L. L.; Melikian-Badalian, A.; Baevsky, M.; Ballas, L. M.; Hall, S. E. Bioorg. Med. Chem. Lett. 1995, 5, 2093.CrossRefGoogle Scholar
- 6.Jirousek, M. R.; Gillig, J. R.; Gonzalez, C. M.; Heath, W. F.; McDonald III, J. H.; Neel, D. A.; Rito, C. J.; Singh, U.; Stramm, L. E.; Melikian-Badalian, A.; Baevsky, M.; Ballas, L. M.; Hall, S. E.; Winneroski, L. L.; Faul, M. M. J. Med. Chem. 1996, 39, 2664.CrossRefGoogle Scholar
- 7.Bartlett, S.; Beddard, G. S.; Jackson, R. M.; Kayser, V.; Kilner, C.; Leach, A.; Nelson, A.; Oledzki, P. R.; Parker, P.; Reid, G. D.; Warriner, S. L. J. Am. Chem. Soc. 2005, 127, 11699.CrossRefGoogle Scholar
- 8.Grodsky, N.; Li, Y.; Bouzida, D.; Love, R.; Jensen, J.; Nodes, B.; Nonomiya, J.; Grant, S. Biochemistry 2006, 45, 13970.CrossRefGoogle Scholar
- 9.Simonov, A. Yu.; Lakatosh, S. A.; Luzikov, Yu. N.; Reznikova, M. I.; Susova, O. Yu.; Shtil’, A. A.; Elizarov, S. M.; Danilenko, V. N.; Preobrazhenskaya, M. N. Russ. Chem. Bull., Int. Ed. 2008, 57, 2011. [Izv. Akad. Nauk, Ser. Khim. 2008, 1977.]Google Scholar
- 10.Lakatosh, S. A.; Luzikov, Y. N.; Preobrazhenskaya, M. N. Org. Biomol. Chem. 2003, 1, 826.CrossRefGoogle Scholar
- 11.Simonov, A. Yu.; Bykov, E. E.; Lakatosh, S. A.; Luzikov, Yu. N.; Korolev, A. M.; Reznikova, M. I.; Preobrazhenskaya, M. N. Tetrahedron 2014, 70, 625.CrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media, LLC, part of Springer Nature 2019